|A Blog by The Dore (Theodore)||
In the hearts of men, and especially that of biological science, is the desire to save human life under the dangers of disease and natural decay and to even extend it beyond natural means, a sentiment shared by Dr. Frankenstein in Frankenstein, a novel that portrays the motivation that fuels the passion of different individuals in science. For years, many scientists have studied the human body and have developed numerous innovative technology to achieve such a goal. One of the fields of this development are artificial human organs. This growing problem in our world is that a large amount of unfortunate individuals are in need of new organ transplants due to medical reasons. The list for transplants are veritably long, the requirements are difficult to meet, and the surgeries are risky to perform. This leaves a large amount of people unable to receive treatment and therefore unable to lead a normal, healthy life.
A new source of hope for those with heart issues comes in the form of Cormat, a medical technology company based in France. Cormat have been researching and developing to make accessible to the world the first biocompatible, auto-regulated artificial heart, whose design is extremely similar to that of the human heart with its right and left ventricles. This artificial heart has the capabilities of regulating heart rate and blood flow through the use of the latest electronic sensors. Furthermore, it is coated with a synthetic skin that prevents the bodies of recipients from rejecting it. Already, the artificial hearts have been successfully implanted in patients. Now it is awaiting further development, approval to enter its industrialization phase, and marketing. Soon, the availability of this technology will help solve the problem of donor shortages and be the next large breakthrough in the field of science and medicine.